ISO/TS 20399-2:2018 Preview

Biotechnology -- Ancillary materials present during the production of cellular therapeutic products -- Part 2: Best practice guidance for ancillary material suppliers

This document provides guidance for ancillary material (AM) suppliers to maintain a high level of lot-to-lot consistency in the aspects of identity, purity, stability, biosafety, performance, as well as the accompanying documentation.

This document is applicable to cellular therapeutic products, including gene therapy products whereby cells form part of the final product. It does not apply to products without cells.

The AMs described in this document include those of biological origin [e.g. sera, media (including media additives), growth factors, and monoclonal antibodies] and chemical origin. This document does not address dimethyl sulfoxide (DMSO) for cryopreservation, beads, scaffolds, feeder cells, apparatus and instruments, or additives used post bioprocessing.

This document does not cover the selection, assessment or control of starting materials and excipients.

NOTE International, regional or national regulations or requirements can also apply to specific topics covered in this document.


General information

  • Status :  Published
    Publication date : 2018-11
  • Edition : 1
    Number of pages : 11
  • :
    ISO/TC 276
    Biotechnology
  • 07.080
    Biology. Botany. Zoology

Buy this standard

Format Language
PDF + ePub
Paper
  • CHF58

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)

Keep up to date with ISO

Sign up to our newsletter for the latest news, views and product information

Subscribe